CVS

CVS Health

Stock NYSE – Stock Market Prices, News & Analysis

CVS Health Corp is an American company offering a wide range of healthcare services including pharmacies, care clinics, and pharmaceutical benefits management solutions.

$ 73.49
1.37 %

CVS Health

$ 73.49
1.37 %
CVS

CVS Health Corp is an American company offering a wide range of healthcare services including pharmacies, care clinics, and pharmaceutical benefits management solutions.

Price history of CVS Health
Price history of CVS Health

Performance & Momentum

6 Months 3.60 %
1 Year 13.01 %
3 Years 8.46 %
5 Years 16.84 %

Strategic Analysis

CVS Health • 2026

CVS Health relies on an integrated model combining pharmaceutical distribution, primary care services through its clinics, and pharmaceutical benefit management. This vertical integration provides a competitive advantage in optimizing patient care pathways and controlling healthcare costs in the United States.

Strengths
  • Market leader in a high-demand healthcare sector with a diversified offering
  • Ability to leverage digitalization and the rise of local care services
  • Increased confidence from insiders reflecting positive visibility on mid-term performance
Weaknesses
  • Sensitivity to regulatory and political changes in U.S. healthcare
Momentum

CVS Health's momentum is strong, driven by a notable recent progression and increased confidence from insiders for 2025. This dynamism validates the relevance of its vertical integration strategy and suggests resilience in the face of the sector's cyclical challenges.

Analysis performed 1 month ago

Similar stocks to CVS Health

Recent News

CVS Health

illustration
CVS Health boosts focus on prevention and wellness
1 month ago

CVS Health (NYSE: CVS) is repositioning its pharmacies as health and wellness hubs, with a strong emphasis on prevention, particularly through dedicated heart health programs. Concurrently, the company is expanding its offering by launching the haircare brand "being," which targets a variety of hair types. This strategic shift reinforces CVS's role as a major player in the retail health sector, drawing investor interest, including from Larry Robbins, for whom CVS constitutes a significant part of his portfolio. Despite a slight drop in Q4 profits, the business momentum and institutional confidence (88% ownership) indicate stable growth potential.

illustration
CVS Health Soars with Insider Confidence in 2025
2 months ago

After a challenging 2024 with a 43% drop, CVS Health shares surged over 80% in 2025. This outstanding performance ranks CVS among the top dividend stocks of the year. Company insiders have notably increased their holdings by $2.10 million, signaling strong confidence in the turnaround. Additionally, JPMorgan keeps CVS on its top picks list, projecting a further 19% growth. This positive momentum could continue to drive value appreciation in the stock market.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone